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Abstract
Despite considerable research on hormone-mediated maternal effects in birds, the underlying physiology remains poorly
understood. This study investigated a potential regulation mechanism for differential accumulation of gonadal hormones in
bird eggs. Across vertebrates, glucocorticoids can suppress reproduction by downregulating gonadal hormones. Using the
chicken as a model species, we therefore tested whether elevated levels of plasma corticosterone in female birds influence
the production of gonadal steroids by the ovarian follicles and thus the amount of reproductive hormones in the egg yolk.
Adult laying hens of two different strains (ISA brown and white Leghorn) were implanted subcutaneously with
corticosterone pellets that elevated plasma corticosterone concentrations over a period of nine days. Steroid hormones
were subsequently quantified in plasma and yolk. Corticosterone-implanted hens of both strains had lower plasma
progesterone and testosterone levels and their yolks contained less progesterone and testosterone. The treatment also
reduced egg and yolk mass. Plasma estrogen concentrations decreased in white Leghorns only whereas in both strains yolk
estrogens were unaffected. Our results demonstrate for the first time that maternal plasma corticosterone levels influence
reproductive hormone concentrations in the yolk. Maternal corticosterone could therefore mediate environmentally
induced changes in yolk gonadal hormone concentrations. In addition, stressful situations experienced by the bird mother
might affect the offspring via reduced amounts of reproductive hormones present in the egg as well as available nutrients
for the embryo.
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Introduction
Birds have proven to be excellent models to study hormone-
mediated maternal effects in an evolutionary framework [1].
Pioneered by Schwabl [2], research on avian yolk steroid
hormones has quickly expanded and has revealed for example
that concentrations of yolk hormones vary according to the
prevailing environmental conditions experienced by the laying
female, such as habitat quality in wild birds [1] or the housing
conditions in domestic chickens [3]. Other studies found that the
mothers’ own body condition [4] and the quality of her partner [5]
can affect the concentrations of yolk steroid hormones. Changes
over the laying season, as maternal condition deteriorates, have
also been discovered [1,6]. Besides androgens, which are
investigated in the majority of studies, also gestagens and estrogens
have been measured in the yolk of various bird species [2,7–10]
and environmental cues perceived by the female bird also seem to
influence their concentrations [3,11,12]. Since yolk hormones
affect several fitness components of the embryo, nestling and
juvenile stages, maternal manipulation of yolk hormones is
regarded a strategy to maximize maternal fitness [1,13,14].
Although adaptive functional and evolutionary studies continue
to proliferate rapidly, the underlying physiological mechanism that
enables the female to regulate the steroid hormone content of her
eggs remains unresolved, hampering progress in the field [15]. In
mammals, glucocorticoids (GC) can influence the synthesis of
gonadal steroids both by downregulation of the gonadotrophins
[16,17] and via direct effects on the testis and the ovaries [18–20].
Similarly, it has been shown for birds that concentrations of LH
decrease due to corticosterone elevation [21,22], but stress might
also directly inhibit gonadal hormone production [23]. In the
present study we therefore explored the potential role of GC on
the synthesis of reproductive hormones and their accumulation in
the egg. Our aim was to test whether corticosterone from the
peripheral circulation influences gonadal hormone concentrations
in the eggs of domestic chickens. We therefore experimentally
elevated concentrations of maternal plasma corticosterone by
implanting adult laying hens with corticosterone-releasing pellets
and quantified gonadal hormones in the plasma of the hens and in
the yolk of their eggs. First we performed a pilot experiment to
establish the dose for treatment. Our results demonstrate that
elevating maternal plasma corticosterone levels decreases repro-
ductive hormone concentrations in the yolk.
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Ethics Statement
This project was approved by the Institutional Animal Care and
Use Committee of the University of Groningen (Permit Number:
DEC 5124).
Pilot study
Methods and results. We wanted to obtain yolks that were
formed while plasma corticosterone concentrations were
constantly elevated. Once recruited into the follicular hierarchy,
chicken follicles undergo a rapid growth phase during the final 6–
11 days before ovulation [24,25]. Our aim was therefore to elevate
maternal plasma corticosterone concentrations for at least 10 days.
We initially tested four different dosages of corticosterone-
releasing pellets on three laying hens each. The pellets, obtained
from Innovative Research of America (Sarasota, FL, USA), were
designed for 60 days of continuous release of a total of 5 mg,
15 mg, 20 mg or 30 mg corticosterone, respectively. Chickens (for
details see below) were caught and blood-sampled within 30
seconds to obtain baseline plasma levels of corticosterone. After
disinfection of the skin in the flank region with alcohol and local
lidocain application (XylocainH Pumpspray, AstraZeneca,
London, UK), a small incision was made into the skin with a
scalpel. Using a blunt probe we created a subcutaneous pocket into
which the pellet was inserted and closed the incision with one or
two stitches afterwards. To assess the effectiveness of the
corticosterone implants, hens were blood-sampled on days 2, 5,
7, 15, 20 and 34 after implantation. Blood samples were analysed
for corticosterone as described below. We found a dose dependent
transient peak in plasma corticosterone levels during the first days
after implantation (Fig. 1). We chose to implant our chickens with
the pellets of the 30 mg dosage in the main experiment as only this
dosage elevated plasma corticosterone for the time necessary for
egg formation. Hens implanted with this dose did not stop egg
laying.
Main experiment
Experimental animals. We used 20 white Leghorn and 20
ISA brown females aged 33 weeks and 10 sexually mature Rhode
Island Red males in our main experiment. Animals were housed
outdoors in May and June in ten aviaries (1.5 m63 m), each of
which contained two females from each strain and one male.
Aviaries were separated from one another by wooden partitions.
Commercial layer feed and water were provided ad libitum. Each
aviary contained a laying nest, which was used by all four females.
ISA brown hens are on average heavier than white Leghorns, but
females were distributed such that in each aviary one white
Leghorn hen was heavier than one ISA brown hen. Average body
mass (mean6SEM) prior to implantation was 1.7660.04 kg in
ISA brown hens and 1.5560.02 kg in white Leghorns,
respectively. Five weeks before the implantation, rank order was
assessed as described by Mu ¨ller et al. [26]. In all aviaries, the two
white Leghorn females were dominant over the two ISA brown
hens and the heavier ISA brown hen was always dominant over
the lighter hen. In only four out of ten aviaries was the heavier
white hen dominant over the lighter white hen.
Treatment, blood sampling, egg collection and sample
sizes. All hens were implanted with pellets as described above.
Half of the females received 30 mg corticosterone pellets and the
other half placebo pellets as control. The distribution of the pellets
was balanced over rank and strain. Blood samples of about 0.5 ml
were collected from the branchial vein on the day of implantation
(day 0) and on days 1, 3, 6, 9 and 12 after implantation. Plasma
samples were taken between 9 a.m. and 6 p.m. on the day of the
implantation (day 0). After implantation, birds were blood sampled
on the respective days between 12 a.m. and 3 p.m. in a random
order.
The egg laying rate for each hen was assessed from 13 days
before until 21 days after implantation. Mean (6SEM) number of
eggs laid per day per individual prior to implantation was 0.88
(60.02) for white Leghorns and 0.91 (60.03) for ISA brown hens.
To identify the eggs from the four individual females within each
aviary we used powdered food colours that were administered into
the cloacae of the hens on every other day, starting three weeks
before the treatment. After the pellet-implantation, food colour
was applied on the same days as the blood samples were drawn. As
this method leaves subtle colour spots on the shell, every egg could
be assigned to the correct female during the sampling period. Eggs
were collected daily from day 0 (day of implantation) until day 19
after implantation. The collected eggs were kept at 4uC for four
days at maximum until they arrived at the lab. There they were
stored at -20uC until analysis for hormone concentrations was
performed as described below. Eggs from days 12, 13, 15, 16 and
18 were incubated and hatched to assess the effects of maternal
stress on the offspring (Henriksen et al., in prep).
The treatment failed in two of the corticosterone pellet-
implanted ISA brown hens, i.e. their plasma corticosterone
concentrations did not increase and the area under the curve
was smaller than the highest values found in the placebo-
implanted group. All eggs and plasma samples collected from
these two females were therefore excluded from further analysis.
The sample size for the blood samples in the hierarchical models
(see below) was therefore ten females from each strain in the
placebo pellet-implanted group and eight ISA brown and ten
white Leghorn females in the corticosterone pellet-implanted
group. After the implantation surgery, four hens stopped laying
(two of the placebo pellet-implanted white Leghorns and one hen
of each strain with corticosterone implants). The numbers of
females in the yolk hormone and egg parameter analyses were
therefore ten ISA browns with placebo pellets (135 eggs), seven
Figure 1. Corticosterone concentrations in plasma after pellet
implantation. Mean (6 SE) concentrations of corticosterone in plasma
of each three hens implanted with 90-day corticosterone release pellets
in four different pellet dosages (7.5 mg #,1 5m g.,2 0m g& and
30 mgN).
doi:10.1371/journal.pone.0023824.g001
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pellet-implanted white Leghorns (98 eggs) and nine corticosterone
pellet-implanted white Leghorns (82 eggs), respectively. In total,
407 eggs were collected and analysed. The number of eggs laid per
day ranged from 22 to 34 since not all females produced eggs on
all days.
Steroid hormone analysis. Plasma samples of 0.1 ml were
extracted with diethyl ether, resuspended in 300 ml assay buffer and
analysed via enzyme immunoassay (EIA) for corticosterone (antibody
against corticosterone-3-CMO; [27]), testosterone (antibody against
testosterone-3-CMO; [28]), progesterone (antibody against 5b-
pregnane-3a-ol-20-one-3-HS; [29]) and estrogens (antibody against
17b-estradiol-17-HS; [28]). Sensitivities of the assays were 3 pg/well
for the corticosterone EIA, 0.3 pg/well for the testosterone EIA,
0.1 pg/well for the estrogen EIA and 1.7 pg/well for the
progesterone EIA. Intra- and inter-assay CV were 12% and 24%,
respectively for the corticosterone EIA, 9% und 16% for the
testosterone EIA, 20% and 25% for the progesterone EIA and 12%
and 15% for the estrogen EIA.
The eggs collected for hormone analysis were weighed and
defrosted until the albumin could be scraped off from the yolk with
a spatula and the yolks were weighed. Concentrations of gonadal
hormones in the yolk were measured with the EIAs mentioned
above. As concentrations vary between the different regions of the
yolk [8,9,30], we prepared three layers from each yolk to assess the
hormone concentrations in the exterior, intermediate and interior
regions of the yolk sphere. Samples were extracted by mixing
0.15 g of yolk with 0.6 ml of double-distilled water, homogenizing
with a hand vortex and freezing overnight. On the next day,
samples were shaken for 15 min before 3 ml of methanol were
added. The mixture was shaken for 30 min and centrifuged at
2500 g for 15 min. For analysis with the progesterone EIA, the
methanolic suspensions were simply diluted 1:100 with assay
buffer. For analysis with the testosterone and the estrogen EIA,
1 ml of the supernatant was transferred into a new vial.
Eprouvettes were placed in a water bath at 60 C and the
methanol evaporated under a stream of nitrogen. Samples were
then resuspended in 0.5 ml of assay buffer. The minimum
detectable hormone level was 0.29 ng per gram yolk for the
testosterone EIA, 100 ng/g for the progesterone EIA and
0.07 ng/g for the estrogen EIA.
Hormone concentrations of whole yolks were calculated by
multiplying the measured concentrations of each layer with the
calculated weight of the respective layer, as described by
Rettenbacher et al. [31], thereby considering that the different
layers would contribute different amounts of yolk if homogenized
prior to analysis.
Avian follicle cells have the enzymatic capacity to synthesize a
plethora of steroid hormones and hormone metabolites [32] and it
is therefore likely that yolk contains various steroids that have not
yet been identified. The measured signal in the yolk might thus in
fact be caused by two or more hormones or hormone metabolites
that bind to the respective antibodies. We will refer to
immunoreactive substances detected by our testosterone antibody
as ‘‘yolk testosterone’’, this term however including also other
androgens and androgen metabolites that have a 17b-hydroxy
structure, likewise we use ‘‘yolk progesterone’’ as characterized by
Rettenbacher et al. [33] for substances measured with the
progesterone antibody and ‘‘yolk estrogens’’, comprising uncon-
jugated estrogens measured with the estrogen antibody.
Statistical analysis. Data were analysed using the statistical
software packages Statistica (StatSoft Inc., Tulsa, OK), SigmaStat
(Systat Software Inc., San Jose, CA) and MlwiN (Version1.10.0007;
[34]), the latter being able to accommodate hierarchical models to
deal with a nested structure of unbalanced data. Two hierarchy
levels were chosen for plasma hormones, yolk hormones and egg
mass (samples within females within aviaries) and three levels for the
hormone data of the different yolk layers (layers within egg within
females within aviaries). Concentrations of plasma corticosterone
and yolk testosterone were log transformed, all other plasma
hormones and yolk progesterone were square-root transformed to
meet criteria of normal distribution. In all models we tested the
effects of treatment, time, strain as well as treatment*strain and
treatment*time interactions. If the treatment*strain interaction was
significant, each strain was tested post-hoc in a separate model,
otherwise the interaction was removed from the model. Non-
significant treatment*time interactions were removed from the final
models, to assess a possible overall treatment effect. Results with an
alpha ,0.05 (two tailed t-test) were regarded as significant.
Treatment effects within layers were also assessed in separate
models for each layer. Yolk progesterone concentrations of the
individual layers were not tested in a hierarchical model, as a
normal distribution could not be achieved. Comparisons of the
individual layers between treatment groups were therefore made via
Mann-Whitney U-tests. Data are shown as means 6 standard error
of the mean (SEM). Plasma hormone concentrations on the
individual days were also compared between the two treatment
groups by using t-tests. Changes in laying performance before and
after the implantation were calculated for each hen and treatments
and strains were compared via ANOVA.
Results
Plasma hormone concentrations
Concentrations of plasma corticosterone were significantly
elevated by treatment (treatment*time interaction: x
2=7.3;
df=1; p=0.007), reaching peak concentrations during the first
days after implantation, after which they gradually decreased
(Fig. 2a). Treatment differences between strains were not detected
(treatment*strain: x
2=0.02; df=1; p=0.89 and removed from
the model). When treatments were compared on individual days,
plasma corticosterone concentrations of the corticosterone pellet-
implanted hens were significantly higher from day one until day
nine after implantation (day 0 p=0.99; day 1, 3, 6 and 9 p,0.001;
day 12 p= 0.07). Concentrations of plasma testosterone were
significantly decreased by the corticosterone pellet implantation,
independent of strain and time (treatment: x
2=57; df=1;
p,0.001; treatment*strain x
2=3.38; df=1; p=0.066 and
removed from the model; all other terms and interactions
p$0.17), from day one onwards during the entire sampling period
(Fig. 2b; day 0 p= 0.9; day one p=0.001; days three and six
p,0.001; day nine p=0.02; day 12 p=0.007). Concentrations of
plasma progesterone were also significantly decreased by treat-
ment (treatment*time x
2=3.88; df=1; p=0.049) from day one
onwards during the entire sampling period (Fig. 2c; day 0 p=0.6;
day one p=0.048; days three and six p=0.005; day nine p=
0.004; day twelve p=0.03). Differences between strains were not
detected (treatment*strain x
2=0.51; df=1; p=0.475 and re-
moved from the model; strain x
2=0.69; df=1; p=0.4). Plasma
estrogens were affected only in the white Leghorn strain (Fig 3a;
treatment*strain: x
2= 21.79; df=1; p,0.001), where treatment
decreased estrogen concentrations in the corticosterone pellet-
implanted white Leghorn hens on day one (p,0.001), three
(p,0.001) and six (p=0.008) after implantation (post-hoc test:
treatment*time: x
2=4.93; df=1; p=0.026). This effect was not
found in hens of the ISA brown strain (Fig 3b; post-hoc test:
treatment*time: x
2=1.16; df=1; p=0.28).
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Implanting hens with corticosterone pellets decreased the
concentrations of yolk testosterone (Fig 4a; treatment*time
x
2=6.56; df=1; p=0.01; treatment*strain x
2=2.51; df=1;
p=0.11 and removed from the model). Mean (6SEM) yolk
testosterone concentrations of all analysed eggs laid after
implantation were 360.1 ng/g yolk in eggs from the corticoste-
rone-implanted and 3.660.1 ng/g yolk for the placebo-implanted
hens, respectively. Similarly, levels of yolk progesterone were also
lower in eggs of the corticosterone-treated hens, with mean
progesterone concentrations of 3156674 ng/g yolk compared to
3430678 ng/g yolk in controls (Fig 4b; treatment: x
2=5.5; df=1;
p=0.019; treatment*time and treatment*strain not significant and
removed from the model; p$0.40). Yolk estrogens were not
significantly affected by the treatment (Fig. 4c; treatment: x
2=15;
df=1; p=0.7; treatment*time: x
2=0.65; df=1; p=0.42 and
treatment*strain: x
2=2.2; df=1; p=0.14 and removed from the
final model) with mean yolk estrogen concentrations of eggs from
corticosterone- and placebo-implanted hens being 2.360.1 ng/g
yolk and 2.060 ng/g yolk, respectively. Independent of treatment,
ISA brown hens had significantly higher concentrations of yolk
steroid hormones compared to white Leghorns. Mean concentra-
tions of yolk testosterone (strain: x
2=31.6; df=1; p,0.001) for
corticosterone-implanted females were 3.360.1 ng/g and
2.761 ng/g for ISA browns and white Leghorns and 460.1 ng/
g and 3.160.1 ng/g for placebo-implanted ISA browns and white
Figure 2. Hormone concentrations in plasma after pellet
implantation. Mean (6SE) concentrations of corticosterone (a),
testosterone (b), progesterone (c) in plasma of hens implanted with
corticosterone (N) or placebo (#) pellets. Asterisks indicate significant
differences between treatments on individual days (*** p#0.001;
** p#0.01; * p#0.05; t-tests).
doi:10.1371/journal.pone.0023824.g002
Figure 3. Estrogen concentrations in plasma after pellet
implantation. Mean (6SE) concentrations of estrogens in plasma of
white Leghorns (a) and ISA browns (b), after implantation with
corticosterone (N) or placebo (#) pellets. Asterisks indicate significant
differences between treatments on individual days (*** p#0.001;
** p#0.01; * p#0.05; t-tests).
doi:10.1371/journal.pone.0023824.g003
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3316699 ng/g and 29756106 ng/g for corticosterone-implanted
and 36546107 ng/g and 31276106 ng/g for placebo-implanted
ISA browns and white Leghorns, respectively (strain: x
2=13.3;
df=1; p,0.001) and yolk estrogen concentrations were
2.560.1 ng/g and 1.960.1 ng/g for corticosterone- and
2.160.1 ng/g and 1.960 ng/g for placebo-implanted ISA browns
and white Leghorns, respectively (strain: x
2=6.8; df=1;
p=0.009).
As treatment affected hormone concentrations differently in the
three yolk layers (treatment*layer x
2=8.51; df=2; p=0.014), we
tested hormone concentrations in the yolk layers in separate
models. Implanting corticosterone-releasing pellets decreased yolk
testosterone in the outermost layer (treatment: x
2=30.1; df=1;
p,0.001) with mean concentrations of 3.060.1 ng/g yolk and
3.760.1 ng/g in yolks from corticosterone-treated and control
females and a similar tendency for the concentration in the inner
layer of the yolks to decrease (treatment: x
2=3.7; df=1;
p=0.052; mean concentrations 260.1 ng/g and 1.860.1 ng/g).
Yolk testosterone concentrations in the middle layer were also
lower in the corticosterone implanted females, but this difference
did not reach statistical significance (3.160.1 ng/g and
3.660.1 ng/g in yolks of corticosterone- and placebo pellet-
implanted females respectively; treatment: x
2=2.7; df=1;
p=0.099; treatment*time: p$0.08 for all layers in the respective
models). Comparisons of the individual layers between treatment
groups via Mann-Whitney U-tests did not reveal significant
differences between yolk progesterone concentrations (p$0.11 in
all tests). We found mean concentrations of 40146116 ng/g and
42216103 ng/g for the outer, 1415676 ng/g and 1444679 ng/g
for the middle and 319640 ng/g and 311628 ng/g yolk for the
inner layers of the yolk in corticosterone pellet- and placebo pellet-
implanted females, respectively.
Egg parameters
Egg mass was lower in corticosterone-implanted hens (treat-
ment: x
2=58.36; df=1; p,0.001; treatment*strain: x
2=0.18
df=1; p=0.67 and treatment*time: x
2=2.69; df=1; p=0.1 and
removed from the model) and varied significantly over time
independent from treatment (time: x
2=4.02; df=1; p=0.04)
whereas differences between strains were not detected (strain:
x
2=0.18; df=1; p=0.67). Mean egg mass was 57.660.4 g for
corticosterone pellet-implanted hens and 61.360.3 g for eggs from
hens implanted with placebo pellets.
Yolk mass was significantly lower in eggs from corticosterone
pellet-implanted hens (Fig. 5a; treatment*time: x
2=6.87; df=1;
p=0.009) and affected the two strains differently (treatment*-
strain: x
2=4.64; df=1; p=0.031) with the yolk mass decrease
being more pronounced in ISA brown hens than in the white
Leghorns (post-hoc tests for ISA browns and white Leghorns:
treatment*time: x
2=6; df=1; p=0.01 and x
2=4.7; df=1;
p=0.03, respectively). Yolks of corticosterone-treated ISA brown
females had an average mass of 13.960.2 g, compared to
15.860.2 g in controls. In white Leghorns, mean yolk mass was
14.360.2 g and 15.560.1 g for corticosterone- and placebo pellet-
implanted females, respectively. To assess egg mass differences
that are not explained by the decrease in yolk mass, we subtracted
yolk mass from egg mass to derive an estimate of the mass of both
shell plus albumin together. Mean shell plus albumin mass was
43.560.3 g in eggs from corticosterone-implanted hens and this
was significantly lower than in hens implanted with placebos,
which laid eggs with a mean shell plus albumin mass of
45.660.3 g (Fig 5b; treatment: x
2=22.86; df=1; p,0.001;
treatment*strain x
2=1.9; df=1; p=0.16 and treatment*time
x
2=0.63; df=1; 0.426 and removed from the model).
Treatment effect on egg laying
Egg laying decreased significantly in corticosterone pellet-
implanted white Leghorn females only (F(3,34)=4.42; p=0.03).
Mean (6SEM) number of eggs laid between day 0 and day 19
after implantation was 1261.9 for white Leghorns with cortico-
sterone pellets, 1860.48 for ISA browns with corticosterone pellets
and 17.560.6 and 18.560.54 for white Leghorns and ISA browns
with placebo implants, respectively.
Figure 4. Hormone concentrations in yolk after pellet implan-
tation. Mean (6SE) concentrations of testosterone (a), progesterone
(b) and estrogens (c) in yolks from hens implanted with with
corticosterone (N) or placebo (#) pellets. Eggs from days 12, 13, 15,
16 and 18 were incubated to hatch chicks. Note that progesterone
concentrations are a thousand-fold higher than the other two steroid
hormones.
doi:10.1371/journal.pone.0023824.g004
Maternal Corticosterone and Yolk Hormones
PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e23824Discussion
Despite extensive research on hormone-mediated maternal
effects in birds, the physiological mechanism by which a female
bird deposits different amounts of gonadal hormones into her eggs
is still unresolved. The present study investigated the potential
effect of corticosterone on gonadal hormones in maternal plasma
and egg yolk. Our findings indicate that elevating plasma
corticosterone concentrations suppressed gonadal hormone syn-
thesis in the ovarian follicles, which was reflected in decreased
concentrations of reproductive hormones in both plasma and yolk.
Effectiveness of the corticosterone implants
Implanting laying hens with corticosterone-releasing pellets
designed for 60 days of continuous corticosterone release elevated
plasma corticosterone concentrations for only nine days post
implantation with a pronounced peak during the first three days.
This is in accordance with observations made by Bonier et al. [35]
and Mu ¨ller et al. [36], who used pellets of the same provider in
other bird species and also found much shorter elevations than
indicated by the manufacturer. From this we conclude that these
pellets elevate plasma corticosterone concentrations in birds much
shorter than in mammals. This might be due to an increase in
metabolic clearance rate by enhanced enzymatic activity, faster
breakdown of the biodegradable matrix of the pellet and/or a
downregulation of binding globulins and should be investigated in
more detail.
Deposition of radiolabelled hormones or substances such as
Sudan dyes into the yolk of chickens occurs during the last 11 days
of yolk formation [25,31,37] and an additional 25-hour period is
necessary for albumin and shell formation [38]. Therefore in the
present study, all eggs collected until day 19 after implantation
were therefore at least partly yolked when the females’ plasma
corticosterone levels were elevated.
Effects on reproductive steroid hormones
Yolks produced by corticosterone pellet-implanted females
contained less yolk testosterone and progesterone than yolks from
placebo pellet-implanted females.
Females implanted with corticosterone pellets also had lower
plasma progesterone and testosterone concentrations. This is
consistent with the fact that GC are generally considered
hormones with antigonadotropic action, as they shift physiological
functions away from reproduction towards survival, especially
under long-term conditions [20]. Stressful conditions such as high
temperatures have also been shown to down-regulate the plasma
concentrations of reproductive hormones in chickens [39]. In
accordance with our results, Okuliarova et al. [40] found lower
testosterone concentrations in the follicles of Japanese quails under
severe restraint stress. A recent study in quails revealed that
confrontation with humans also decreases testosterone and
androstenedione but elevates yolk progesterone levels [11].
Housing quails in unstable groups however increased yolk
testosterone concentrations, whereas yolk progesterone and
androstenedione were unaffected [12]. These inconsistent findings
suggest that different types of stressors exert different effects on
yolk steroid hormones and illustrate that further research is
necessary. Despite its presence in high concentrations, yolk
progesterone has not received much attention in the past and its
role in the development of the bird embryo is unknown. The
finding that progesterone and other gestagen metabolites affect the
growth of chick embryo cartilage [41] however suggests a possible
role for these hormones in the development of bird embryos. In
mammals, prenatal progesterone is known to enhance cognitive
ability [42].
Gonadal hormones are produced by the theca and granulosa
cells of the ovarian follicle [43]. During the course of maturation,
the steroidogenic activity of a follicle changes due to different
responsiveness to LH and FSH stimuli [44]. When we analyzed
steroid hormone concentrations of the different yolk layers
separately, we found the most pronounced decrease of yolk
testosterone in the outer layers of the yolk, which are produced at
a later stage. It might therefore be possible, that the corticosterone
treatment affected the individual follicles differently, depending on
their actual maturation stage. Our findings suggest that larger
follicles were more affected, whereas small follicles are less
susceptible. As estrogens are synthesized exclusively by the early
stage follicles [45], this would also explain why estrogens were least
affected by our treatment. In white Leghorns, plasma estrogens
were only suppressed for three days, whereas progesterone and
testosterone concentrations were lower during the entire sampling
period. This is in accordance with findings in white Leghorns [39],
where heat stress affected concentrations of plasma estrogens less
than plasma testosterone or progesterone and suggests that the
smaller follicles either recover faster and resume their estrogen
production or that they are quickly replaced by new re-growing
follicles.
One might wonder why estrogen concentrations decreased in
the plasma but not yolks of white Leghorns. Although there are
still many open questions regarding the relationship between
plasma and yolk hormone concentrations and more knowledge
Figure 5. Egg mass after pellet implantation. Mean (6SE) yolk
mass (a) and shell plus albumin mass (b) in eggs from hens implanted
with corticosterone (N) or placebo (#) pellets. Eggs from days 12, 13,
15, 16 and 18 were incubated to hatch chicks.
doi:10.1371/journal.pone.0023824.g005
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and egg is therefore certainly necessary [15], we believe we have
identified several reasons why linking plasma and yolk hormone
concentrations at the individual level might be hampered: First,
yolk hormone levels reflect hormone accumulation within an
individual follicle over a certain period of time, thereby integrating
hormone production over several days, whereas plasma hormones
represent a single time point measurement. Also, plasma
concentrations can fluctuate due to changes in blood volume,
enhanced clearance from blood via enzymatic degradation,
changes in binding proteins, etc., whereas potential influences on
the amount of hormones that are transferred into the yolk are still
largely unknown. Furthermore, plasma concentrations represent a
pool into which all active follicles contribute, whereas yolk
hormones are mostly produced by the cells surrounding the
individual follicles [14,15]. The latter is supported by the fact that
yolk steroid hormones vary among yolk layers, reflecting both
amount and type of hormones produced during the maturation of
the individual follicle. In addition, yolk contains a mixture of
several different hormones or hormone metabolites [33]. There-
fore, the measured concentration in the yolk might be caused by
several immunoreactive substances which bind to the antibody. If
those hormones are not present in similar proportions in the
plasma, a potential correlation between plasma and yolk hormone
concentrations cannot be detected.
Moreover, we observed no difference in plasma hormone levels
between the two strains, whereas concentrations of yolk testoster-
one, estrogens and progesterone were higher in eggs from ISA
brown hens than in white Leghorns, irrespective of treatment. To
our knowledge, differences in concentrations of yolk steroid
hormones have not been assessed previously between layer hen
strains. Yolk hormone concentrations in quails are highly heritable
[46,47], suggesting a genetic component to variations. The
observed differences in yolk steroid hormone concentrations
between the two chicken strains could be due to either differences
in hormones production, or because different amounts of
hormones are transferred actively or passively into the yolks. For
the latter, strain differences in yolk composition might also be
relevant [48].
Effects on egg parameters and egg laying
Our treatment decreased laying performance only in white
Leghorns, whereas yolk mass reduction was seen in both strains
although more pronounced in the ISA brown hens. Implantation
with corticosterone pellets also decreased shell and albumin mass
in both strains. Corticosterone treatment has been shown to
reduce the production of yolk precursors in the liver [49], to
decrease egg mass [50] and to suppress laying performance
[21,51]. These effects could be due to the down-regulation of
gonadal hormones, which are essential for reproduction [24], but
may also be explained by the fact that glucocorticoids influence
both protein and fat metabolism in birds [52,53] and thus yolk
formation. Our treatment decreased concentrations of yolk
testosterone and progesterone as well as yolk mass, thus resulting
in an overall reduction of total hormone content in the eggs.
Smaller yolks would also limit the amount of nutrients available for
the chick embryo. In mammals, fetal malnutrition is one of the
main mediators of maternal stress, because GC can compromise
placental capacity for nutrient transfer [54]. As the exact modes of
action of maternally derived hormones on the bird embryo have so
far been described only partially [55], it remains largely unknown
by which mechanisms the altered composition and amounts of egg
components affect the developing offspring.
Whether corticosterone itself was transferred to the eggs due to
the treatment was not assessed in the present study. Hormone
transfer from plasma to yolk is generally low [30,31], but high
concentrations of plasma corticosterone, e.g. after feeding 0.1 g of
crystallized corticosterone were reflected in elevated yolk cortico-
sterone concentrations [31]. It has to be noted however, that
quantification of corticosterone in the yolk is not a straightforward
procedure: As we showed recently, the high concentrations of
gestagens present in egg yolk of chickens interfer with the
quantification of corticosterone via immunoassays [33]. To assess
whether quantification of yolk corticosterone is possible via other
analytical methods was beyond the scope of this study. In the
present study we investigated a possible physiological mechanism
responsible for varying concentrations of reproductive hormones
in bird eggs. Our current findings indicate that corticosterone from
the mothers’ circulation can modulate the concentrations of
testosterone and progesterone in the yolk of domestic chickens.
They also suggest that maternal stress affects the bird embryo
indirectly via reproductive hormones and nutrient amount. As we
artificially elevated plasma corticosterone levels, further investiga-
tions are necessary to clarify whether a more natural stressor
triggers similar physiological responses in egg-laying females and
whether wild bird species respond in the same way as domestic
chickens.
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